M H J van Oers
Overview
Explore the profile of M H J van Oers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerritsen M, Brinkman P, Escobar N, Bos L, de Heer K, Meijer M, et al.
Med Mycol
. 2017 May;
56(2):253-256.
PMID: 28525576
Volatile organic compounds (VOCs) in exhaled breath may identify the presence of invasive pulmonary aspergillosis. We aimed to detect VOC profiles emitted by in vitro cultured, clinical Aspergillus isolates using...
2.
Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, et al.
Ann Oncol
. 2017 Apr;
28(7):1436-1447.
PMID: 28379322
In recent years, the number of approved and investigational agents that can be safely administered for the treatment of lymphoma patients for a prolonged period of time has substantially increased....
3.
Thijssen R, Ter Burg J, van Bochove G, de Rooij M, Kuil A, Jansen M, et al.
Leukemia
. 2016 Sep;
30(9):1963.
PMID: 27600169
No abstract available.
4.
de Heer K, Vonk S, Kok M, Kolader M, Zwinderman A, van Oers M, et al.
J Breath Res
. 2016 Jul;
10(3):036008.
PMID: 27447026
Invasive pulmonary mold disease (IPMD) is often fatal in neutropenic patients. This is because IPMD is difficult to diagnose timely, especially when non-Aspergillus molds are the causative agent, as they...
5.
de Heer K, Kok M, Fens N, Weersink E, Zwinderman A, van der Schee M, et al.
J Clin Microbiol
. 2016 Jun;
54(7):1926.
PMID: 27343292
No abstract available.
6.
Fleury I, Chevret S, Pfreundschuh M, Salles G, Coiffier B, van Oers M, et al.
Ann Oncol
. 2015 Dec;
27(3):390-7.
PMID: 26681685
Background: Addition of the anti-CD20 monoclonal antibody rituximab to chemotherapy improves response rates and survival in patients with B-cell non-Hodgkin lymphoma (NHL). However, rituximab induces a transient B-cell depletion and...
7.
de Heer K, Kok M, Fens N, Weersink E, Zwinderman A, van der Schee M, et al.
J Clin Microbiol
. 2015 Dec;
54(3):569-75.
PMID: 26677251
Currently, there is no noninvasive test that can reliably diagnose early invasive pulmonary aspergillosis (IA). An electronic nose (eNose) can discriminate various lung diseases through an analysis of exhaled volatile...
8.
Thijssen R, Ter Burg J, van Bochove G, de Rooij M, Kuil A, Jansen M, et al.
Leukemia
. 2015 Sep;
30(2):337-45.
PMID: 26338274
The phosphoinositide 3-kinases (PI3Ks) are critical components of the B-cell receptor (BCR) pathway and have an important role in the pathobiology of chronic lymphocytic leukemia (CLL). Inhibitors of PI3Kδ block...
9.
Holtzer-Goor K, Schaafsma M, Joosten P, Posthuma E, Wittebol S, Huijgens P, et al.
Qual Life Res
. 2015 Jul;
24(12):2895-906.
PMID: 26205768
Purpose: To describe the health-related quality of life (HRQoL) of an unselected population of patients with chronic lymphocytic leukaemia (CLL) including untreated patients. Methods: HRQoL was measured by the EORTC...
10.
te Raa G, Derks I, Navrkalova V, Skowronska A, Moerland P, van Laar J, et al.
Leukemia
. 2014 Nov;
29(5):1133-42.
PMID: 25371178
Mutations or deletions in TP53 or ATM are well-known determinants of poor prognosis in chronic lymphocytic leukemia (CLL), but only account for approximately 40% of chemo-resistant patients. Genome-wide sequencing has...